Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
ADC Therapeutics SA (ADCT) had Income from Continuous Operations of $-40.97M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$16.43M |
|
$-40.97M |
|
$1.20M |
|
$15.22M |
|
$47.40M |
|
$-30.97M |
|
$-10.00M |
|
$-40.97M |
|
$-40.97M |
|
$-40.97M |
|
|
Income from Continuous Operations |
$-40.97M |
$-40.97M |
|
$-40.97M |
|
$-30.97M |
|
$-30.85M |
|
136.45M |
|
136.45M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$287.15M |
|
-- |
|
$2.61M |
|
$289.76M |
|
$62.04M |
|
$115.21M |
|
$465.90M |
|
$527.94M |
|
$-238.18M |
|
$-238.18M |
|
$-238.18M |
|
112.63M |
|
| Cash Flow Statement Financials | |
$-110.05M |
|
$-0.26M |
|
$93.86M |
|
$250.87M |
|
$234.74M |
|
$-16.13M |
|
$6.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.63 |
|
-- |
|
-- |
|
-0.94 |
|
-0.48 |
|
92.68% |
|
-188.53% |
|
-188.53% |
|
-- |
|
-249.38% |
|
-249.38% |
|
$-110.31M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.07 |
|
0.72 |
|
125.56 |
|
17.20% |
|
17.20% |
|
-14.14% |
|
33.31% |
|
$-2.11 |
|
$-0.81 |
|
$-0.81 |
|